86 related articles for article (PubMed ID: 1332873)
21. Evidence for lack of modulation of mu-opioid agonist action by delta-opioid agonists in the mouse vas deferens and guinea-pig ileum.
Elliott J; Traynor JR
Br J Pharmacol; 1995 Mar; 114(5):1064-8. PubMed ID: 7780641
[TBL] [Abstract][Full Text] [Related]
22. mu-Opioid receptor-regulated adenylate cyclase activity in primary cultures of rat striatal neurons upon chronic morphine exposure.
Van Vliet BJ; De Vries TJ; Wardeh G; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1991 Oct; 208(2):105-11. PubMed ID: 1666051
[TBL] [Abstract][Full Text] [Related]
23. A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor.
Minami M; Nakagawa T; Seki T; Onogi T; Aoki Y; Katao Y; Katsumata S; Satoh M
Mol Pharmacol; 1996 Nov; 50(5):1413-22. PubMed ID: 8913373
[TBL] [Abstract][Full Text] [Related]
24. Bremazocine is an agonist at kappa-opioid receptors and an antagonist at mu-opioid receptors in the guinea-pig myenteric plexus.
Corbett AD; Kosterlitz HW
Br J Pharmacol; 1986 Sep; 89(1):245-9. PubMed ID: 3026544
[TBL] [Abstract][Full Text] [Related]
25. The electrophysiological effects of [D-Ala2,N-Me-Phe4,Gly5-ol]enkephalin on guinea-pig myenteric neurons.
Pillai NP; Johnson SM
Eur J Pharmacol; 1991 Jan; 192(2):227-33. PubMed ID: 2032556
[TBL] [Abstract][Full Text] [Related]
26. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
Noble F; Cox BM
Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
[TBL] [Abstract][Full Text] [Related]
27. Endomorphins fully activate a cloned human mu opioid receptor.
Gong J; Strong JA; Zhang S; Yue X; DeHaven RN; Daubert JD; Cassel JA; Yu G; Mansson E; Yu L
FEBS Lett; 1998 Nov; 439(1-2):152-6. PubMed ID: 9849897
[TBL] [Abstract][Full Text] [Related]
28. Bimodal opioid regulation of cyclic AMP formation: implications for positive and negative coupling of opiate receptors to adenylyl cyclase.
Wang L; Gintzler AR
J Neurochem; 1994 Nov; 63(5):1726-30. PubMed ID: 7931327
[TBL] [Abstract][Full Text] [Related]
29. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
Prather PL; Tsai AW; Law PY
J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
[TBL] [Abstract][Full Text] [Related]
30. Agonist-induced signaling and trafficking of the mu-opioid receptor: role of serine and threonine residues in the third cytoplasmic loop and C-terminal domain.
Capeyrou R; Riond J; Corbani M; Lepage JF; Bertin B; Emorine LJ
FEBS Lett; 1997 Sep; 415(2):200-5. PubMed ID: 9350996
[TBL] [Abstract][Full Text] [Related]
31. Regulatory role of enteric mu and kappa opioid receptors in the release of acetylcholine and norepinephrine from guinea pig ileum.
Nakayama S; Taniyama K; Matsuyama S; Ohgushi N; Tsunekawa K; Tanaka C
J Pharmacol Exp Ther; 1990 Sep; 254(3):792-8. PubMed ID: 1975621
[TBL] [Abstract][Full Text] [Related]
32. Determination of levels of cyclic AMP in the myenteric plexus of guinea-pig small intestine.
Xia Y; Baidan LV; Fertel RH; Wood JD
Eur J Pharmacol; 1991 Mar; 206(3):231-6. PubMed ID: 1713166
[TBL] [Abstract][Full Text] [Related]
33. FlCRhR/cyclic AMP signaling in myenteric ganglia and calbindin-D28 intrinsic primary afferent neurons involves adenylyl cyclases I, III and IV.
Liu CY; Jamaleddin AJ; Zhang H; Christofi FL
Brain Res; 1999 May; 826(2):253-69. PubMed ID: 10224303
[TBL] [Abstract][Full Text] [Related]
34. Opioid inhibition of cholinergic transmission in the guinea-pig ileum is independent of intracellular cyclic AMP.
Johnson SM
Eur J Pharmacol; 1990 May; 180(2-3):331-8. PubMed ID: 1694775
[TBL] [Abstract][Full Text] [Related]
35. Reversible modulation of opioid receptor binding in intact neural cells by endogenous guanosine triphosphate.
Yabaluri N; Medzihradsky F
Mol Pharmacol; 1995 Oct; 48(4):690-5. PubMed ID: 7476895
[TBL] [Abstract][Full Text] [Related]
36. Agonist-induced functional desensitization of the mu-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein.
Pak Y; Kouvelas A; Scheideler MA; Rasmussen J; O'Dowd BF; George SR
Mol Pharmacol; 1996 Nov; 50(5):1214-22. PubMed ID: 8913353
[TBL] [Abstract][Full Text] [Related]
37. Dual effects of DAMGO [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) on adenylyl cyclase activity: implications for mu-opioid receptor Gs coupling.
Szücs M; Boda K; Gintzler AR
J Pharmacol Exp Ther; 2004 Jul; 310(1):256-62. PubMed ID: 14996951
[TBL] [Abstract][Full Text] [Related]
38. Ligand-selective activation of mu-oid receptor: demonstrated with deletion and single amino acid mutations of third intracellular loop domain.
Chaipatikul V; Loh HH; Law PY
J Pharmacol Exp Ther; 2003 Jun; 305(3):909-18. PubMed ID: 12626655
[TBL] [Abstract][Full Text] [Related]
39. Opioids can enhance and inhibit the electrically evoked release of methionine-enkephalin.
Xu H; Smolens I; Gintzler AR
Brain Res; 1989 Dec; 504(1):36-42. PubMed ID: 2574620
[TBL] [Abstract][Full Text] [Related]
40. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
Liu JG; Prather PL
Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
